Shares of Liberty Biopharma Inc (CVE:LTY – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.
Liberty Biopharma Stock Performance
The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19. The firm has a 50 day moving average of C$2.00 and a 200-day moving average of C$2.00. The company has a market cap of C$21.54 million and a P/E ratio of -12.66.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Recommended Stories
- Five stocks we like better than Liberty Biopharma
- Should You Invest in Penny Stocks?
- 4 Cold-Weather Stocks to Buy as Winter Spending Heats Up
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Disney Stock Drops—Will Earnings Pave Way for a YouTube TV Truce?
- How to Use Stock Screeners to Find Stocks
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
